GBMM: A graph-based multimodal Mamba model for response prediction in patients with esophageal squamous cell carcinoma receiving neoadjuvant immunochemotherapy.
OBJECTIVE Neoadjuvant immunochemotherapy (NICT) can improve outcomes in advanced esophageal squamous cell carcinoma, but its efficacy varies significantly among patients. Accurately predicting response to NICT before treatment can help identify those who may benefit and avoid ineffective treatment. However, this remain...